AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
IN-VITRO DRUG-INDUCED CYTOTOXICITY PREDICTS CLINICAL-RESPONSE TO FLUDARABINE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MORABITO F STELITANO C CALLEA I DATTOLA A CONSOLE G PUCCI G IACOPINO P CALLEA V DIRAIMONDO F BRUGIATELLI M
Citation: F. Morabito et al., IN-VITRO DRUG-INDUCED CYTOTOXICITY PREDICTS CLINICAL-RESPONSE TO FLUDARABINE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 102(2), 1998, pp. 528-531
PREDICTION OF RESPONSE TO CHLORAMBUCIL IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), MODEL DERIVED FROM LOGISTIC-REGRESSION ANALYSIS ON 291 PATIENTS IN IGCI CLL TRIALS
Authors: JAKSIC O BRUGIATELLI M IACOPINO P MORABITO F PLANINCPERAICA A MINIGO H LUTZ D JAKSIC B
Citation: O. Jaksic et al., PREDICTION OF RESPONSE TO CHLORAMBUCIL IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), MODEL DERIVED FROM LOGISTIC-REGRESSION ANALYSIS ON 291 PATIENTS IN IGCI CLL TRIALS, British Journal of Haematology, 102(1), 1998, pp. 196-196
IN-VITRO IMPROVEMENT OF CHLORAMBUCIL-INDUCED CYTOTOXICITY BY DEFLAZACORT AND 6-METHYLPREDNISOLONE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MORABITO F CALLEA I IRRERA G CARTISANO G DATTOLA A RODINO A BRUGIATELLI M
Citation: F. Morabito et al., IN-VITRO IMPROVEMENT OF CHLORAMBUCIL-INDUCED CYTOTOXICITY BY DEFLAZACORT AND 6-METHYLPREDNISOLONE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, European journal of haematology, 58(5), 1997, pp. 301-306
THE IN-VITRO CYTOTOXIC EFFECT OF MITOXANTRONE IN COMBINATION WITH FLUDARABINE OR PENTOSTATIN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MORABITO F CALLEA I CONSOLE G STELITANO C SCULLI G FILANGERI M OLIVA B MUSOLINO C IACOPINO P BRUGIATELLI M
Citation: F. Morabito et al., THE IN-VITRO CYTOTOXIC EFFECT OF MITOXANTRONE IN COMBINATION WITH FLUDARABINE OR PENTOSTATIN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Haematologica, 82(5), 1997, pp. 560-565
BCL-2 PROTEIN EXPRESSION AND P53 GENE MUTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH IN-VITRO SENSITIVITY TO CHLORAMBUCIL AND PURINE ANALOGS
Authors: MORABITO F FILANGERI M CALLEA I SCULLI G CALLEA V FRACCHIOLLA NS NERI A BRUGIATELLI M
Citation: F. Morabito et al., BCL-2 PROTEIN EXPRESSION AND P53 GENE MUTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH IN-VITRO SENSITIVITY TO CHLORAMBUCIL AND PURINE ANALOGS, Haematologica, 82(1), 1997, pp. 16-20
HIGH-DOSE CHLORAMBUCIL VERSUS BINET MODIFIED CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE REGIMEN IN THE TREATMENT OF PATIENTS WITH ADVANCED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RESULTS OF AN INTERNATIONAL MULTICENTER RANDOMIZED TRIAL
Authors: JAKSIC B BRUGIATELLI M KRC I LOSONCZI H HOLOWIECKI J PLANINCPERAICA A KUSEC R MORABITO F IACOPINO P LUTZ D
Citation: B. Jaksic et al., HIGH-DOSE CHLORAMBUCIL VERSUS BINET MODIFIED CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE REGIMEN IN THE TREATMENT OF PATIENTS WITH ADVANCED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - RESULTS OF AN INTERNATIONAL MULTICENTER RANDOMIZED TRIAL, Cancer, 79(11), 1997, pp. 2107-2114
LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL
Authors: BRUGIATELLI M CLAISSE JF LENORMAND B MORABITO F CALLEA V MALLOUM K CHEVRET S BINET JL DIGHIERO G TRAVADE P
Citation: M. Brugiatelli et al., LONG-TERM CLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, British Journal of Haematology, 97(1), 1997, pp. 113-118
PERIPHERAL CD34(- PRELIMINARY-RESULTS OF A COOPERATIVE STUDY() CELL AUTOGRAFT IN CLL )
Authors: SCIME R SANTORO A MUSSO M OLIVIERI A MOLICA S BRUGIATELLI M IACOPINO P MILONE G GIUSTOLISI R LISO V GUGLIELMI G LEONI P NARNI F DONELLI A MAJOLINO I
Citation: R. Scime et al., PERIPHERAL CD34(- PRELIMINARY-RESULTS OF A COOPERATIVE STUDY() CELL AUTOGRAFT IN CLL ), Blood, 90(10), 1997, pp. 4580-4580
COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL)
Authors: BRUGIATELLI M FEDERICO M GOBBI P DIRENZO N VALLISA D ANGRILLI F COLOMBI M ASCARI E SILINGARDI V AMADORI S
Citation: M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840
CHLORAMBUCIL MAINTENANCE SIGNIFICANTLY IMPROVES SURVIVAL IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - METAANALYSIS OF IGCI CLL TRIALS
Authors: JAKSIC B BRUGIATELLI M STELITANO C MORABITO F CALLEA V JAKSIC O PLANINCPERAICA A LUTZ D
Citation: B. Jaksic et al., CHLORAMBUCIL MAINTENANCE SIGNIFICANTLY IMPROVES SURVIVAL IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - METAANALYSIS OF IGCI CLL TRIALS, Blood, 90(10), 1997, pp. 2362-2362
2-CHLORODEOXYADENOSINE TREATMENT IN NON-HODGKINS-LYMPHOMA AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO CONVENTIONAL CHEMOTHERAPY - RESULTS OF A MULTICENTRIC EXPERIENCE
Authors: BRUGIATELLI M HOLOWIECKA B DMOSZYNSKA A KRIEGER O PLANINCPERAICA A LABAR B CALLEA V MORABITO F JAKSIC B HOLOWIECKI J LUTZ D
Citation: M. Brugiatelli et al., 2-CHLORODEOXYADENOSINE TREATMENT IN NON-HODGKINS-LYMPHOMA AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO CONVENTIONAL CHEMOTHERAPY - RESULTS OF A MULTICENTRIC EXPERIENCE, Annals of hematology, 73(2), 1996, pp. 79-84
CLINICAL-SIGNIFICANCE OF SIL2R, SCD23, SICAM-1, IL6 AND SCD14 SERUM LEVELS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: CALLEA V MORABITO F LUISE F PIROMALLI A FILANGERI M STELITANO C IACOPINO P NOBILE F BRUGIATELLI M
Citation: V. Callea et al., CLINICAL-SIGNIFICANCE OF SIL2R, SCD23, SICAM-1, IL6 AND SCD14 SERUM LEVELS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Haematologica, 81(4), 1996, pp. 310-315
IN-VITRO SENSITIVITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS TO FLUDARABINE, 2-CHLORODEOXYADENOSINE AND CHLORAMBUCIL - CORRELATION WITH CLINICOHEMATOLOGICAL AND IMMUNOPHENOTYPIC FEATURES
Authors: MORABITO F STELITANO C CALLEA I FILANGERI M OLIVA B SCULLI G CALLEA V NOBILE F BRUGIATELLI M
Citation: F. Morabito et al., IN-VITRO SENSITIVITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS TO FLUDARABINE, 2-CHLORODEOXYADENOSINE AND CHLORAMBUCIL - CORRELATION WITH CLINICOHEMATOLOGICAL AND IMMUNOPHENOTYPIC FEATURES, Haematologica, 81(3), 1996, pp. 224-231
PROPHYLAXIS AGAINST INFECTIONS WITH LOW-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIG) IN CHRONIC LYMPHOCYTIC-LEUKEMIA - RESULTS OF A CROSSOVER STUDY
Authors: MOLICA S MUSTO P CHIURAZZI F SPECCHIA G BRUGIATELLI M CICOIRA L LEVATO D NOBILE F CAROTENUTO M LISO V ROTOLI B
Citation: S. Molica et al., PROPHYLAXIS AGAINST INFECTIONS WITH LOW-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIG) IN CHRONIC LYMPHOCYTIC-LEUKEMIA - RESULTS OF A CROSSOVER STUDY, Haematologica, 81(2), 1996, pp. 121-126
INTERNATIONAL PROGNOSTIC INDEX (IPI) AND AGE-ADJUSTED IPI (AA-IPI) ARE IMPROVED BY TUMOR BURDEN (TD) EVALUATION
Authors: GRIGNANI G BRUGIATELLI M GOBBI PG PIERESCA C DIRENZO N IANNITTO E MOLICA S SANTAGATI G GINALDI L CARACCIOLO F SILINGARDI V
Citation: G. Grignani et al., INTERNATIONAL PROGNOSTIC INDEX (IPI) AND AGE-ADJUSTED IPI (AA-IPI) ARE IMPROVED BY TUMOR BURDEN (TD) EVALUATION, Blood, 88(10), 1996, pp. 905-905
FLUDARABINE VS HIGH-DOSE CONTINUOUS CHLORAMBUCIL - INTERIM ANALYSIS OF A RANDOMIZED PHASE-II STUDY IN UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: JAKSIC B DELMER A BRUGIATELLI M SUCIU S BAUMELOU E ROOZENDAAL KJ WIJERMANS PW JEHN U TEIXEIRA A PEETERS E SOLBU G ZITTOUN R WILLEMZE R
Citation: B. Jaksic et al., FLUDARABINE VS HIGH-DOSE CONTINUOUS CHLORAMBUCIL - INTERIM ANALYSIS OF A RANDOMIZED PHASE-II STUDY IN UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 88(10), 1996, pp. 2342-2342
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+ KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS/
Authors: LONGO G FEDERICO M PIERESCA C AVANZINI P IANNITTO E DIPRISCO AU BALDINI L BRUGIATELLI M CLO V BEVINI M SILINGARDI V
Citation: G. Longo et al., ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+ KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS/, European journal of cancer, 31A(11), 1995, pp. 1763-1767
TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN EARLY AND STABLE PHASE OF THE DISEASE - LONG-TERM RESULTS OF A RANDOMIZED TRIAL
Authors: BRUGIATELLI M JAKSIC B PLANINCPERAICA A KUSEC R OSTOJIC S CALLEA V IACOPINO P MORABITO F STELITANO C LUTZ D
Citation: M. Brugiatelli et al., TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN EARLY AND STABLE PHASE OF THE DISEASE - LONG-TERM RESULTS OF A RANDOMIZED TRIAL, European journal of haematology, 55(3), 1995, pp. 158-163
MODULATION OF PURINE ANALOGS-INDUCED AND CHLORAMBUCIL-INDUCED CYTOTOXICITY BY ALPHA-INTERFERON AND INTERLEUKIN-2 IN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MORABITO F CALLEA I RODINO A MESSINA G CALLEA V IACOPINO P NOBILE F BRUGIATELLI M
Citation: F. Morabito et al., MODULATION OF PURINE ANALOGS-INDUCED AND CHLORAMBUCIL-INDUCED CYTOTOXICITY BY ALPHA-INTERFERON AND INTERLEUKIN-2 IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia, 9(9), 1995, pp. 1450-1455
PROPHYLAXIS AGAINST INFECTIONS WITH INTRAVENOUS IMMUNOGLOBULINS IN MULTIPLE-MYELOMA
Authors: MUSTO P BRUGIATELLI M CAROTENUTO M
Citation: P. Musto et al., PROPHYLAXIS AGAINST INFECTIONS WITH INTRAVENOUS IMMUNOGLOBULINS IN MULTIPLE-MYELOMA, British Journal of Haematology, 89(4), 1995, pp. 945-946
SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL
Authors: BRUGIATELLI M CLAISSE JF LENORMAND B MORABITO F CALLEA V MALLOUM K CHEVRET S BINET JL DIGHIERO G TRAVADE P
Citation: M. Brugiatelli et al., SCLINICAL OUTCOME OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) PATIENTS IN CLINICAL REMISSION PHASE EVALUATED AT PHENOTYPIC LEVEL, Blood, 86(10), 1995, pp. 1377-1377
COMPARISON OF HIGH-DOSE CHLORAMBUCIL VERSUS BINETS MODIFIED CHOP REGIMEN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN ADVANCED PHASE - RESULTSOF AN INTERNATIONAL MULTICENTRIC RANDOMIZED TRIAL
Authors: JAKSIC B BRUGIATELLI M KRC I LOSONCZI H HOLOWIECKI J LABAR B SCHRANZ V PLANINCPERAICA A KUSEC R MORABITO F IACOPINO P LUTZ D
Citation: B. Jaksic et al., COMPARISON OF HIGH-DOSE CHLORAMBUCIL VERSUS BINETS MODIFIED CHOP REGIMEN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN ADVANCED PHASE - RESULTSOF AN INTERNATIONAL MULTICENTRIC RANDOMIZED TRIAL, Blood, 86(10), 1995, pp. 2415-2415
LONG-TERM RESULTS OF ALPHA-INTERFERON AS INITIAL THERAPY AND SPLENECTOMY AS CONSOLIDATION THERAPY IN PATIENTS WITH HAIRY-CELL LEUKEMIA - FINAL REPORT FROM THE ITALIAN COOPERATIVE GROUP FOR HCL
Authors: FEDERICO M FRASSOLDATI A LAMPARELLI T FOA R BRUGIATELLI M ANNINO L BALDINI L CAPNIST G CHISESI T DICELLE PF INVERNIZZI R LAURIA F TRUINI M RESEGOTTI L SILINGARDI V DAMASIO EE
Citation: M. Federico et al., LONG-TERM RESULTS OF ALPHA-INTERFERON AS INITIAL THERAPY AND SPLENECTOMY AS CONSOLIDATION THERAPY IN PATIENTS WITH HAIRY-CELL LEUKEMIA - FINAL REPORT FROM THE ITALIAN COOPERATIVE GROUP FOR HCL, Annals of oncology, 5(8), 1994, pp. 725-731
COMPARISON OF YOUNGER VERSUS OLDER B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS FOR CLINICAL PRESENTATION AND PROGNOSIS - A RETROSPECTIVE STUDY OF 53 CASES
Authors: MOLICA S BRUGIATELLI M CALLEA V MORABITO F LEVATO D NOBILE F ALBERTI A
Citation: S. Molica et al., COMPARISON OF YOUNGER VERSUS OLDER B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS FOR CLINICAL PRESENTATION AND PROGNOSIS - A RETROSPECTIVE STUDY OF 53 CASES, European journal of haematology, 52(4), 1994, pp. 216-221
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL
Authors: BRUGIATELLI M FEDERICO M GOBBI PG AVANZINI P CALLEA V CAVANNA L DEPASQUALE A DIPRISCO AU DIRIENZO N SILINGARDI V MAURI C
Citation: M. Brugiatelli et al., EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL, Haematologica, 78(5), 1993, pp. 306-312
Risultati: 1-25 | 26-26